Blog Archives

IS SUFFICIENT DATA AVAILABLE TO MEET HEALTH-ECONOMIC REQUIREMENTS ACROSS EUROPE?

Prague, Czech Republic – Many Central & Eastern European (CEE) countries have recently introduced mandatory health economic (HE) evaluations to grant reimbursements for medical technologies. Health economic requirements in the CEE countries are often aligned to Western European standards, mainly

Tagged with: , , ,
Posted in Health Policy Analyses, Value in Health Regional Issues

Inconsistency Among Utility Values in Japanese Studies –Are All QALYs Created Equal?

Tochigi, Japan – To conduct cost–utility analyses (CUAs) for pharmaceuticals, substantial data are required. One part of these data contains the utility values used when calculating the quality-adjusted life year (QALY). Using utility data in clinical trials in Japan was uncommon;

Tagged with: , , ,
Posted in Value in Health Regional Issues

Cost-Utility Analysis Of Erythropoietin For Hemodialysis Patients

Bangkok, Thailand – Most patients receiving hemodialysis (HD) for end-stage renal disease (ESRD) currently receive erythropoietin (EPO) for anemia treatment. The goal of therapy is to achieve specific hemoglobin (Hb) target levels. Higher doses of EPO are used to attain higher

Tagged with: , , , ,
Posted in Value in Health Regional Issues

Challenges In Valuing The Impact Of Sexually Transmitted Infections

Birmingham, United Kingdom – Sexually transmitted infections like chlamydia are a global public health concern. Chlamydia can cause infertility and other reproductive tract problems in women. Health policy decision makers need to know which interventions they should prioritise to get the

Tagged with: , , , ,
Posted in Systematic Reviews, Value in Health

Can Pharmaceutical Care Interventions Improve Type 2 Diabetes Management?

Enugu State, Nigeria – Cost-utility analysis was developed to help decision makers compare the values of alternative interventions. With the increasing demand for better management of type 2 diabetes, attention has been focused on the potential benefits of pharmaceutical care (PC)

Tagged with: , , ,
Posted in Value in Health Regional Issues

Italian Social Tariffs For QALYs Calculation Are Now Available

Milano and Napoli, Italy – The Italian health care system is starting to take information on HRQoL and QALYs into consideration when deciding on the utilization of available resources. Although comparisons of different national value sets have demonstrated the existence of

Tagged with: , , , , , ,
Posted in Preference-Based Assessments, Value in Health
Categories
Follow ISPOR
RSS FeedFriend me on FacebookFollow my company on LinkedInFollow me on TwitterWatch me on YouTube